Moukeh Ghamez, Yacoub Rabi, Fahdi Fadi, Rastam Samer, Albitar Sami
Department of Nephrology, Aleppo University, Aleppo, Syria.
Saudi J Kidney Dis Transpl. 2009 Jan;20(1):140-6.
To determine the characteristics of the hemodialysis (HD) patients in Aleppo city, we surveyed the hospitals representing the main dialysis centers in the city including private and community facilities during 2006. Personal patients' interviews and hospitals records were the source of data. The total number of patients in 2006 undergoing HD was 550 patients; 280 (50.9%) were males, and the age ranged from 5-82 years with mean and median age 44.7 and 45 years, respectively. The incidence (IR) and prevalence rate (PR) for hemodialysis were 60 pmp and 226 pmp, respectively. The major primary renal diseases in the end-stage renal disease (ESRD) patients included hypertension (HTN), glomerulonephritis (GN), and diabetes mellitus (DM), 21.1%, 20.5 %, and 19.45, respectively. The percent of Anti-HCV, HBV hepatitis and HBV vaccine were 54.4%, 7.8%, and 52.9%, respectively. This study suggests that the IR of hemodialysis was relatively low due to the high cost of treatment, and the PR for hemodialysis was also relatively low may be due to high mortality rate and low kidney transplantation rate in this country. There was an equal percentage of both genders in the hemodialysis population.
为了确定阿勒颇市血液透析(HD)患者的特征,我们在2006年对该市代表主要透析中心的医院进行了调查,这些医院包括私立和社区医疗机构。患者个人访谈和医院记录是数据来源。2006年接受血液透析的患者总数为550例;其中280例(50.9%)为男性,年龄范围为5至82岁,平均年龄和中位数年龄分别为44.7岁和45岁。血液透析的发病率(IR)和患病率(PR)分别为60/百万人口和226/百万人口。终末期肾病(ESRD)患者的主要原发性肾脏疾病包括高血压(HTN)、肾小球肾炎(GN)和糖尿病(DM),分别占21.1%、20.5%和19.45%。抗丙型肝炎病毒(Anti-HCV)、乙型肝炎病毒(HBV)肝炎和HBV疫苗接种率分别为54.4%、7.8%和52.9%。本研究表明,由于治疗费用高昂,血液透析的发病率相对较低,而血液透析的患病率也相对较低,这可能是由于该国死亡率高和肾移植率低所致。血液透析人群中男女比例相等。